Cutaneous CD30-positive epithelioid angiosarcoma following breast-conserving therapy and irradiation: a potential diagnostic pitfall.
A case of cutaneous epithelioid angiosarcoma with anomalous CD30 expression, occurring after breast-conserving surgery and adjuvant irradiation, is reported. This seems to be the first such case reported. The differential diagnosis of CD30 epithelioid angiosarcoma is discussed.
Weed
Brent R
BR
Department of Dermatology, Mayo Clinic, Rochester, MN 55905, USA. folpe.andrew@mayo.edu
Folpe
Andrew L
AL
D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000532:radiotherapy / Q000601:surgery; D018270:Carcinoma, Ductal, Breast / Q000532:radiotherapy / Q000601:surgery; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D005260:Female; D006394:Hemangiosarcoma / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D017730:Ki-1 Antigen / Q000096:biosynthesis*; D017728:Lymphoma, Large-Cell, Anaplastic / Q000473:pathology; D009381:Neoplasms, Radiation-Induced / Q000378:metabolism* / Q000473:pathology; D016609:Neoplasms, Second Primary / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects; D012878:Skin Neoplasms / Q000209:etiology / Q000378:metabolism* / Q000473:pathology
D017730:Ki-1 Antigen